Arkolith/Insider Trading/EGRX/Form 4

Edlin Richard A.

DirectorEAGLE PHARMACEUTICALS, INC. (EGRX) · full profile →Form 4 · filed Sep 8, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$211K
Net Open-Market Flow
-$211K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 6, 2022Sell(S)7K$30.99$211K23K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-049205) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML